Sue Ann Wee

1. Hyde K, Warren D, Gavino AC. Primary cutaneous cryptococcal infection with subsequent erythema nodosum in a 10-year-old immunocompetent girl. JAAD Case Rep. 2016;2(6):494-496. doi:10.1016/j.jdcr.2016.09.001 2. Chayakulkeeree M, Perfect J. Cryptococcosis. Infect Dis Clin North Am. 2006;20(3):507-544. doi:10.1016/j.idc.2006.07.001 3. Kaur H, Zaman K, Thapa B, Rudramurthy S. Fatal cryptococcosis involving multiple sites in an immunocompetent child. Indian J Med Microbiol. 2015;33 Suppl:148-150.

Background Botulinum toxin type A (BTX) is used prophylactically to reduce the frequency of migraine headaches, with inconsistent responses reported in the literature. The purpose of our study was to determine whether BTX injections at doses used for upper-face cosmetic purposes, which differ from doses typically used by headache specialists, could prevent imploding and ocular but not exploding migraines.